Results 131 to 140 of about 3,284,156 (346)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Clinical Chemistry, 2009
S. Bustin, V. Beneš, J. Garson, J. Hellemans, J. Huggett, M. Kubista, Reinhold D. Mueller, T. Nolan, M. Pfaffl, G. Shipley, J. Vandesompele, C. Wittwer   +11 more
semanticscholar   +1 more source

Metagenomic 16S rDNA Targeted PCR-DGGE in Determining Bacterial Diversity in Aquatic Ecosystem

, 1970
Nur A. Hasan, Wasimul B. Chowdhury, Md Niaz Rahim, Marzia Sultana, Syeda Antara Shabnam, Volker Mai, Afsar Ali, Glen J Morris, R. Bradley Sack, Anwar Huq, Rita R. Colwell, Hubert P. Endtz, Alejandro Cravioto, Munirul Alam   +13 more
openalex   +2 more sources

Identification and rapid screening of a DraI RFLP by PCR in the retinoblastoma gene [PDF]

, 1994
Nasir Ahmad, Peter H. Dixon, Jordan Shields, Haizhen Dua, LARRY A. DONOSO   +4 more
openalex   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Rapid mapping of Escherichia coli::Tn5 insertion mutations by REP-Tn5 PCR. [PDF]

, 1992
Prem S. Subramanian, James Versalovic, Edward R.B. McCabe, James R. Lupski   +3 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Application of Real Time PCR for the Detection and Enumeration of Vibrio parahaemolyticus from Seafood in Sarawak (Malaysia)

, 1970
Lesley Maurice Bilung, Linang Velnetti, Kasing Apun, Samuel Lihan, Yoke Kqueen Cheah, Mickey Vincent   +5 more
openalex   +2 more sources

Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene [PDF]

, 1994
Hanna Soini, Erik C. Böttger, Matti K. Viljanen   +2 more
openalex   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source